Private Equity Profile
In the last 3 years, 1315 Capital has acquired 3 companies. It has also invested in 1 other.
1315 Capital’s most common sectors for investment are medical products (40%) and life science (30%). The Firm’s most common investment types include venture (40%) and buyout (lbo, mbo, mbi) (20%). In total, 1315 Capital has invested in 6 US states.
In the last 3 years, 1315 Capital has exited 1 company. The Firm’s most common exit type is trade sale (100%). 1315 Capital’s largest (disclosed) exit occurred in 2018 when it sold Genoptix for $126M.
Join Mergr to view 1315 Capital’s full profile and discover more small private equity firms just like it.
M&A Total Activity11
- M&A Buy Activity10
- M&A Sell Activity1
- Total Sectors Invested 5
- Total Countries Invested 1
- M&A Buy/Sell Connections 5